| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvalent, Inc. (NUVL) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 57 sells. NUVL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 202.6K | $25.11M | - | |
| 10% | 3.4K | $426.9K | - | |
| Other | 0 | - | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | Miller Deborah Ann | Chief Legal Officer | Sale+OE | 5,500 | $107.84 | $593,100.52 | -2.2% | - | - | |
| May 28, 2026 | Noci Darlene | Chief Development Officer | Sale+OE | 5,500 | $107.80 | $592,923.04 | -1.8% | - | - | |
| Feb 26, 2026 | Miller Deborah Ann | Chief Legal Officer | Sale+OE | 5,500 | $103.05 | $566,787.54 | -2.9% | +3.2% | - | |
| Feb 26, 2026 | Noci Darlene | Chief Development Officer | Sale+OE | 5,500 | $103.03 | $566,682.00 | -3.0% | +3.2% | - | |
| Jan 6, 2026 | Noci Darlene | Chief Development Officer | Sell | 7,417 | $97.25 | $721,320.39 | -2.4% | +6.7% | - | |
| Jan 6, 2026 | Miller Deborah Ann | Chief Legal Officer | Sell | 6,952 | $97.26 | $676,157.59 | -2.2% | +6.7% | - | |
| Jan 6, 2026 | Balcom Alexandra50 | Chief Financial Officer | Sell | 7,417 | $97.25 | $721,320.39 | -1.2% | +6.7% | - | |
| Jan 6, 2026 | Porter James Richard46 | President And CEO | Sell | 27,433 | $97.26 | $2,668,259.95 | -1.3% | +6.7% | - | |
| Jan 6, 2026 | Pelish Henry E.61 | Chief Scientific Officer | Sell | 5,160 | $97.24 | $501,752.89 | -1.1% | +6.7% | - | |
| Jan 6, 2026 | Turner Christopher Durant | Chief Medical Officer | Sell | 7,417 | $97.25 | $721,320.39 | -1.8% | +6.7% | - |